EUFEPS NOVICE

Round Table Vaccination

https://www.eufeps.org/eventreader/Vaccination.html

 

15. december ob 15ih:

You can register to the meeting with the following link:

https://zoom.us/meeting/register/tJAlduyurD8rH9IkZf81h2UIbDYk2uZyuaS_

 

Program

 

Flash presentations (15 min each)

Prof. Dr. Rogério Gaspar (WHO)

“Regulatory science enablers for pharmaceutical innovation: lessons from a global health emergency”.

Dr. Rosario Cáceres (Spanish Association of Vaccinology)

“Communicating with patients about vaccines”

Dr. Camilla Foged (University of Copenhagen)

“The Danish COVID-19 vaccine rollout”

Rogier Hilbers (Community pharmacist in The Netherlands)

“Pharmacy-based vaccination: a community pharmacy experience”

Panel discussion Panelists: Rogério Gaspar, Rosario Cáceres, Camilla Foged, Rogier Hilbers, Christa Müller (University of Bonn), Ema Paulino (FIP)

5th conference on The Global Harmonization Initiative

28. in 29. september 2022, Amsterdam, The Netherlands

 

The topics of the next conference have been fixed:
•Fed vs fasted studies for immediate release dosage forms: relevance of excipients,disintegration/dissolution specificities, drug substance properties and physiologicalGI    conditions – new findings shall help achieve harmonisation
•Statistical considerations for BE assessment: replicate design for BE of Highly VariableDrugs, two-stage design and PK modelling as supportive tools for BE assessment
•Topical products: Scientifically-based approaches for a waiver of clinical endpointtrials
•Narrow therapeutic index drugs: study design and acceptance criteria

The Global Bioequivalence Harmonisation Initiative is intended to support the process of global harmonization via scientific discussion among international stakeholders. Therefore, a series of international conferences was founded by EUFEPS in collaboration with AAPS supported from the beginning by the European Medicines Agency (EMA) as well as the U.S. Food and Drug Administration (FDA).
Regulators and speakers from other countries/regions, e.g., Canada, Chile, China, India, Japan, Jordan, Mexico, and Brazil, will be invited to the discussions. Such global participation presents an ideal platform for scientists from regulatory agencies, pharmaceutical industry and academia to exchange their experience and scientific viewpoints: scientific consensus should constitute the most appropriate basis for harmonization.
The Organising Committee of the 5th GBHI Workshop is now presenting the topics, date and venue of the next conference. After the 4th conference in Washington in 2019, now
Amsterdam has again been selected as the location. The conference is planned as a hybrid conference in which some participants can attend at the venue – depending on the severity of the Covid-19 pandemic in Europe and worldwide – while offering virtual access to all those who cannot manage to travel to Amsterdam.

Nazaj